Riskpilot← Back to searchSign inGet full accessMOELV FYSIOTERAPI AS
ASActiveOrg 991801367Storgata 133, 2390 MoelvPhysiotherapy activities · NACE 8695Est. 20070 employees
Revenue 2024
NOK 1,5M
+11% vs 2023
EBITDA margin
21.2%
+75% vs 2023
Equity ratio
68.1%
Financial strength
Net profit 2024
NOK 139K
+571% vs 2023
| Revenue | NOK 1,5M | +11% |
| EBITDA | NOK 318K | +75% |
| Net profit | NOK 139K | +571% |
| Total assets | NOK 2,7M | -1% |
| Equity | NOK 1,9M | +8% |
| Employees | 0 | — |
Legal name
MOELV FYSIOTERAPI AS
Org number
991801367
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
13. oktober 2007
Share capital
NOK 102 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og to styremedlemmer i fellesskap.
Company purpose
Fysikalsk praksis og forvalte eiendom samt hva som herved står i forbindelse.
Address
Storgata 133, 2390 Moelv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 047 | 1 196 | 1 245 | 1 355 | 1 503 |
| Staff expenses | −10 | −13 | −13 | −12 | −14 |
| EBITDA | 349 | 327 | 223 | 181 | 318 |
| Depreciation & amort. | −111 | −112 | −114 | −108 | −108 |
| EBIT | 239 | 215 | 109 | 73 | 210 |
| Net financials | −67 | −41 | −45 | −47 | −32 |
| Profit before tax | 172 | 174 | 64 | 27 | 178 |
| Tax | 38 | 38 | 14 | 6 | 39 |
| Net profit | 134 | 136 | 50 | 21 | 139 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 149 | 3 008 | 2 975 | 2 771 | 2 734 |
| Equity | 1 399 | 1 535 | 1 585 | 1 724 | 1 863 |
| Long-term debt | 1 659 | 1 429 | 1 197 | 964 | 731 |
| Short-term debt | 90 | 44 | 193 | 83 | 140 |
| Total debt | 1 750 | 1 473 | 1 390 | 1 047 | 871 |
EBITDA margin
21.2%
This company
15.8%
Market median
+34% vs market
20202024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20202024
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
20202024
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
20202024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
VB Chief Executive Officer | Chief Executive Officer | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Company | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 1.96% | 1.96% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MOELV FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vidar Bernhardsen | Chief Executive Officer | 0 companies |
| Vidar Guldvik Bernhardsen | Chairman | 0 companies |